Russell Investments Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5K | Sell |
|
|||||
|
2025
Q1 | $62.7K | Sell |
|
|||||
|
2024
Q4 | $148K | Buy |
|
|||||
|
2024
Q3 | $220K | Sell |
|
|||||
|
2024
Q2 | $334K | Sell |
|
|||||
|
2024
Q1 | $809K | Sell |
|
|||||
|
2023
Q4 | $874K | Buy |
|
|||||
|
2023
Q3 | $370K | Sell |
|
|||||
|
2023
Q2 | $892K | Buy |
|
|||||
|
2023
Q1 | $981K | Buy |
|
|||||
|
2022
Q4 | $5.34K | Hold |
|
|||||
|
2022
Q3 | $11K | Hold |
|
|||||
|
2022
Q2 | $13K | Hold |
|
|||||
|
2022
Q1 | $20K | Hold |
|
|||||
|
2021
Q4 | $30K | Hold |
|
|||||
|
2021
Q3 | $31K | Sell |
|
|||||
|
2021
Q2 | $427K | Sell |
|
|||||
|
2021
Q1 | $3.19M | Sell |
|
|||||
|
2020
Q4 | $5.43M | Sell |
|
|||||
|
2020
Q3 | $2.73M | Hold |
|
|||||
|
2020
Q2 | $2.34M | Sell |
|
|||||
|
2020
Q1 | $2.2M | Sell |
|
|||||
|
2019
Q4 | $3.08M | Buy |
|
|||||
|
2019
Q3 | $1.41M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $234K | Buy |
|